Katherine Rejeski

Katherine Rejeski at LMU Munich is a hematology fellow and researcher specializing in CAR-T cell therapy and immune effector cell-associated toxicity. Her research on immune effector cell-associated hematotoxicity (ICAHT) and optimal CRS/ICANS management has contributed to improved patient safety protocols for CAR-T administration. She is leading efforts to standardize toxicity grading and management guidelines.